Biocompatible Membrane Composite for Immune Isolation and Vascularization

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Biological therapies face challenges in maintaining the viability of encapsulated cells due to immune responses triggered by foreign body giant cell formation, which restricts vascularization and access to oxygen and nutrients, necessitating a material that provides immune isolation while promoting vascularization near cell encapsulation devices.

Innovation Solution

A biocompatible membrane composite with specific layer configurations, including a cell impermeable layer, a mitigation layer with solid features, and a vascularization layer, designed to minimize foreign body giant cell formation and facilitate vascular ingrowth, comprising layers with distinct pore sizes, thicknesses, and solid feature spacings to ensure nutrient delivery to encapsulated cells.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If a cell impermeable membrane is used to provide immune isolation, then immune protection of encapsulated cells is improved, but foreign body giant cell formation increases and vascularization is restricted

Engineering Contradiction:
Improveimmune protectionVSAvoidforeign body giant cell formation
Core Design Contradiction:
ReliabilityVSObject-affected harmful factors

Solution Approach 1:

The membrane is segmented into three distinct layers with different pore sizes and properties: a first layer (cell impermeable layer) for immune isolation, a second layer (mitigation layer) to reduce foreign body response, and a third layer (vascularization layer) to promote blood vessel formation. This segmentation allows each layer to perform its specific function without interfering with others.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The second layer acts as an intermediary between the first layer (cell impermeable) and the third layer (vascularization). It mitigates the foreign body response that would otherwise occur at the interface between the cell impermeable layer and host tissue, thereby reducing foreign body giant cell formation while still allowing the first layer to provide immune protection.

Inventive Principle:
Principle #24Intermediary (Mediator)

2Productivity

If blood vessels form close to encapsulated cells, then access to oxygen and nutrients is improved, but foreign body giant cell formation restricts vascularization

Engineering Contradiction:
Improvecell viabilityVSAvoidvascularization restriction
Core Design Contradiction:
ProductivityVSObject-affected harmful factors

Solution Approach 1:

Different regions of the membrane have different pore sizes and structures optimized for their specific functions: the first layer has small pores for immune isolation, the second layer has intermediate pores for mitigating foreign body response, and the third layer has large pores for promoting vascularization. This local quality variation allows blood vessels to form close to cells in the third layer without being restricted by foreign body giant cells.

Inventive Principle:
Principle #3Local quality

3Device complexity

If a single layer membrane is used, then device complexity is reduced, but it cannot simultaneously provide immune isolation and promote vascularization

Engineering Contradiction:
Improvemembrane structureVSAvoiddual function capability
Core Design Contradiction:
Device complexityVSAdaptability or versatility

Solution Approach 1:

The membrane is constructed as a composite of three different layers, each with distinct pore sizes and structural properties. This composite structure enables the membrane to simultaneously provide immune isolation (first layer), reduce foreign body response (second layer), and promote vascularization (third layer), achieving dual functionality that a single-layer membrane cannot provide.

Inventive Principle:
Principle #40Composite materials

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The membrane composite effectively reduces foreign body giant cell formation, enhances vascularization, and maintains cell viability by allowing close proximity of blood vessels to the encapsulated cells, thereby supporting the survival and therapeutic function of encapsulated cells.

Implementation Method 1

the first layer has an MPS (maximum pore size) less than about 1 micron... permit the passage of nutrients through but prevent the passage of the cells encapsulated therethrough

Methodology Applied
Scientific EffectDiffusion: Diffusion

Implementation Method 2

a second layer has first solid features with a majority of first solid feature spacing less than about 50 microns... able to mitigate or tailor the foreign body response

Methodology Applied
Scientific EffectSurface topology effect:

Implementation Method 3

a third layer that has a pore size greater than about 5 microns in effective diameter... providing an environment that is able to mitigate or tailor the foreign body response such that sufficient vascularization occurs

Methodology Applied
Scientific EffectVascularization:

Data Source

PatentUS20220234006A1A biocompatible membrane composite
Publication Date: 2022.07.28 VIACYTE INC
  • US20220234006A1 patent drawing
  • US20220234006A1 patent drawing
  • US20220234006A1 patent drawing

AI summary

A biocompatible membrane composite including a first layer (cell impermeable layer), a second layer (a mitigation layer), and a third layer (a vascularization layer) is provided. The mitigation layer may be positioned between the cell impermeable layer and the vascularization layer In some embodiments, the cell impermeable layer and the mitigation layer are intimately bonded to form a composite layer having a tight/open structure. A reinforcing component may optionally be positioned on either side of the biocompatible membrane composite or within the biocompatible membrane composite to provide support to and prevent distortion of the membrane composite. The biocompatible membrane composite may be used in or to form a device for encapsulating biological entities, including, but not limited to, pancreatic lineage type cells such as pancreatic progenitors.